Safety analysis of the LINX device

An analysis of the safety profile of the first 1000 patients worldwide to undergo the LINX reflux management system has now been published in the scientific journal Disease of the Esophagus. The study evaluated detailed, prospectively gathered information from the 82 centres throughout the world, including Exeter, which was the first centre in the UK to offer this through the National Health Service.

The results demonstrate excellent results with a very low complication rate of 0.1%. Long term data regarding the efficacy of LINX, have already been published in the New England Journal of Medicine,  and six-year follow-up in the Journal of the American College of Surgeons in 2013, and this paper now adds increased confidence to clinicians in recommending LINX as definitive treatment for gastro-oesophageal reflux disease.

Disease esophagus logo2untitled (2)untitled